Breaking News Instant updates and real-time market news.

ABUS

Arbutus Biopharma

$5.90

0.25 (4.42%)

05:30
02/15/18
02/15
05:30
02/15/18
05:30

Arbutus Biopharma enters exclusivity agreement with Roivant Sciences

Arbutus Biopharma announced that Arbutus and Roivant entered into an exclusivity agreement providing for a period that expires on March 15, 2018. Pursuant to the Exclusivity Agreement, during this period, Arbutus and Roivant agree to negotiate on an exclusive basis the terms and conditions of a proposal to jointly develop Arbutus' nucleic acid delivery platform based on its Lipid Nanoparticle, or LNP, technology and GalNAc technology, or collectively, Delivery Technologies, through a new company that would jointly own, manage, and develop the Delivery Technologies. There are no assurances that Arbutus and Roivant will reach an agreement regarding any such transaction or that any such transaction will be consummated.

ABUS Arbutus Biopharma
$5.90

0.25 (4.42%)

01/05/18
RILY
01/05/18
INITIATION
Target $10
RILY
Buy
Arbutus Biopharma initiated with a Buy at B. Riley FBR
B. Riley FBR analyst Madhu Kumar started Arbutus Biopharma with a Buy rating and $10 price target.
10/03/17
JMPS
10/03/17
NO CHANGE
Target $13
JMPS
Outperform
Arbutus well positioned to accelerate pipeline growth, says JMP Securities
JMP Securities analyst Liisa Bayko said she believes Arbutus Biopharma is well positioned to accelerate its pipeline growth after striking a deal for additional funding from Roivant Sciences. The analyst, who continues to recommend Arbutus shares as the company approaches key inflection points, keeps an Outperform rating on the stock and raised her price target to $13 from $12 to reflect the near-term cash from the Roivant agreement.
04/04/17
CHDN
04/04/17
UPGRADE
Target $6
CHDN
Buy
Arbutus Biopharma upgraded to Buy from Neutral at Chardan
Chardan analyst Madhu Kumar upgraded Arbutus Biopharma to Buy, raising his price target to $6 from $3. Kumar thinks HBV therapy represents a significant market in infectious disease as multiple RNAi drugs have demonstrated clinical proof of concept for hepatitis B surface antigen suppression, and early HBV combination clinical data looks promising.
03/03/17
WBLR
03/03/17
NO CHANGE
WBLR
HBV space to consolidate over next five years, says William Blair
William Blair analyst Y. Katherine Xu sees curing chronic hepatitis B virus infections as "the next frontier" after the success of hepatitis C treatments and believes the market for an HBV cure could be "similar in size to that of HCV," or $200B in cumulative global sales over a span of two decades. She expects consolidation of the HBV market over the next five years, much like what happened with the HCV market. Xu sees Spring Bank Pharmaceuticals (SBPH) and Arbutus (ABUS) as having the strongest data catalysts in 2017, followed by Assembly Biosciences (ASMB) and Arrowhead (ARWR). She has Outperform ratings on the first three stocks and a Market Perform rating on Arrowhead.

TODAY'S FREE FLY STORIES

WIFI

Boingo Wireless

$21.24

0.48 (2.31%)

12:16
03/21/19
03/21
12:16
03/21/19
12:16
Conference/Events
Boingo Wireless management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 27

    Mar

  • 28

    Mar

  • 29

    Mar

  • 28

    May

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
03/21/19
03/21
12:16
03/21/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$228.37

-92.1 (-28.74%)

, AAPL

Apple

$194.85

6.71 (3.57%)

12:12
03/21/19
03/21
12:12
03/21/19
12:12
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks are rising this…

BIIB

Biogen

$228.37

-92.1 (-28.74%)

AAPL

Apple

$194.85

6.71 (3.57%)

MU

Micron

$43.54

3.46 (8.63%)

F

Ford

$8.63

0.12 (1.41%)

AMZN

Amazon.com

$1,804.86

7.5 (0.42%)

SNAP

Snap

$10.87

-0.07 (-0.64%)

LEVI

Levi Strauss

$22.67

(0.00%)

SRNE

Sorrento Therapeutics

$4.32

0.83 (23.78%)

DRI

Darden

$116.20

7.58 (6.98%)

CSIQ

Canadian Solar

$19.76

-3.78 (-16.06%)

GES

Guess

$19.02

-3.08 (-13.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 21

    Mar

  • 25

    Mar

  • 25

    Mar

  • 26

    Mar

  • 27

    Mar

  • 04

    Apr

  • 24

    Apr

  • 25

    Apr

  • 30

    Apr

  • 01

    May

  • 28

    May

  • 24

    Jul

  • 23

    Oct

  • 21

    Mar

VREX

Varex Imaging

$34.09

0.13 (0.38%)

12:10
03/21/19
03/21
12:10
03/21/19
12:10
Conference/Events
Varex Imaging management to meet with Northland »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 27

    Mar

  • 28

    Mar

CTL

CenturyLink

$11.98

0.08 (0.67%)

12:05
03/21/19
03/21
12:05
03/21/19
12:05
Options
CenturyLink call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:05
03/21/19
03/21
12:05
03/21/19
12:05
General news
Treasury announced a $113 B batch of coupon auctions »

Treasury announced a $113…

X

U.S. Steel

$20.46

0.68 (3.44%)

12:05
03/21/19
03/21
12:05
03/21/19
12:05
Hot Stocks
U.S. Steel announces enhanced benefits for its non-represented employees »

United States Steel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVH

Evolent Health

$13.81

0.655 (4.98%)

12:04
03/21/19
03/21
12:04
03/21/19
12:04
Recommendations
Evolent Health analyst commentary  »

Recent indications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBDO

Banco Bradesco

$10.43

(0.00%)

12:00
03/21/19
03/21
12:00
03/21/19
12:00
Hot Stocks
Banco Bradesco falls -7.2% »

Banco Bradesco is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

I

Intelsat

$15.27

-1.72 (-10.12%)

12:00
03/21/19
03/21
12:00
03/21/19
12:00
Hot Stocks
Intelsat falls -10.1% »

Intelsat is down -10.1%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GES

Guess

$18.96

-3.14 (-14.21%)

12:00
03/21/19
03/21
12:00
03/21/19
12:00
Hot Stocks
Guess falls -14.0% »

Guess is down -14.0%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPG

Crescent Point Energy

$3.53

0.245 (7.46%)

12:00
03/21/19
03/21
12:00
03/21/19
12:00
Hot Stocks
Crescent Point Energy rises 8.0% »

Crescent Point Energy is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAG

Conagra Brands

$25.50

2.595 (11.33%)

12:00
03/21/19
03/21
12:00
03/21/19
12:00
Hot Stocks
Conagra Brands rises 11.4% »

Conagra Brands is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

CHAP

Chaparral Energy

$5.95

0.64 (12.05%)

12:00
03/21/19
03/21
12:00
03/21/19
12:00
Hot Stocks
Chaparral Energy rises 12.2% »

Chaparral Energy is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRZBY

Commerzbank

$0.00

(0.00%)

, DB

Deutsche Bank

$8.48

-0.29 (-3.31%)

11:59
03/21/19
03/21
11:59
03/21/19
11:59
Periodicals
Deutsche Bank board discussed Commerzbank merger for 3 hours, Reuters says »

Deutsche Bank's (DB)…

CRZBY

Commerzbank

$0.00

(0.00%)

DB

Deutsche Bank

$8.48

-0.29 (-3.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$228.26

-92.21 (-28.77%)

11:53
03/21/19
03/21
11:53
03/21/19
11:53
Downgrade
Biogen rating change at Cantor Fitzgerald »

Biogen downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 24

    Apr

  • 30

    Apr

  • 01

    May

  • 28

    May

JAZZ

Jazz Pharmaceuticals

$136.47

2.74 (2.05%)

11:50
03/21/19
03/21
11:50
03/21/19
11:50
Recommendations
Jazz Pharmaceuticals analyst commentary at Wells Fargo »

Jazz appoval expected but…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:50
03/21/19
03/21
11:50
03/21/19
11:50
General news
Treasury's $95 B 4- and 8-week bill sales were mixed »

Treasury's $95 B 4-…

EVH

Evolent Health

$13.74

0.585 (4.45%)

11:47
03/21/19
03/21
11:47
03/21/19
11:47
Recommendations
Evolent Health analyst commentary at KeyBanc »

Kentucky Medicaid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$103.54

1.2 (1.17%)

11:45
03/21/19
03/21
11:45
03/21/19
11:45
Options
PayPal call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$37.75

-0.12 (-0.32%)

11:38
03/21/19
03/21
11:38
03/21/19
11:38
Conference/Events
Boston Scientific management to meet with UBS »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 18

    May

  • 28

    May

ORHOF

Origin House

$0.00

(0.00%)

, ACB

Aurora Cannabis

$9.60

-0.2 (-2.04%)

11:38
03/21/19
03/21
11:38
03/21/19
11:38
On The Fly
Rising High: An exclusive talk with cannabis brands company Origin House »

In this edition of…

ORHOF

Origin House

$0.00

(0.00%)

ACB

Aurora Cannabis

$9.60

-0.2 (-2.04%)

APHA

Aphria

$9.98

-0.15 (-1.48%)

CVSI

CV Sciences

$0.00

(0.00%)

CNTTF

CannTrust Holdings

$0.00

(0.00%)

CRON

Cronos Group

$20.67

-0.59 (-2.78%)

CGC

Canopy Growth

$45.90

-0.9 (-1.92%)

TLRY

Tilray

$69.93

-0.7 (-0.99%)

IGC

India Globalization Capital

$2.02

0.12 (6.32%)

KNHBF

ICC International Cannabis

$0.00

(0.00%)

ORTFD

Biome Grow

$0.00

(0.00%)

MLCPF

MediPharm Labs

$0.00

(0.00%)

OGRMF

Organigram

$0.00

(0.00%)

KSHB

KushCo Holdings

$0.00

(0.00%)

MMNFF

MedMen

$0.00

(0.00%)

ELLXF

Elixinol Global

$0.00

(0.00%)

PLNHF

Planet 13 Holdings

$0.00

(0.00%)

KHRNF

Khiron Life Sciences

$0.00

(0.00%)

LHSIF

Liberty Health Sciences

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

FB

Facebook

$164.56

-0.91 (-0.55%)

11:37
03/21/19
03/21
11:37
03/21/19
11:37
Hot Stocks
Facebook says issues fixed after finding user passwords readable by employees »

Facebook's VP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 03

    Apr

  • 04

    Apr

11:36
03/21/19
03/21
11:36
03/21/19
11:36
General news
8-Week Bill Auction Total Amount data reported »

8-Week Bill Auction Total…

11:36
03/21/19
03/21
11:36
03/21/19
11:36
General news
4-Week Bill Auction Total Amount data reported »

4-Week Bill Auction Total…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.